Dexcom develops continuous glucose monitoring (CGM) systems for diabetes management, using a small under-skin sensor that streams glucose readings to a smartphone or receiver. Its devices are among the most widely used CGMs worldwide, and the company has traded publicly since 2005.
- Founded
- 1999
- Headquarters
- San Diego, California, US
- Founders
- Scott Glenn, John Burd
- Status
- Public (Nasdaq: DXCM)
- Latest round
- IPO (2005)
- Employees
- 10,000+
- Category
- Devices, wearables & remote monitoring
- Products
- Dexcom G7 continuous glucose monitor, Dexcom Stelo
- Website
- www.dexcom.com
Covered in: Mobile Health and Connected Devices
Profile compiled from the public sources listed above. Funding, valuation, and employee figures are point-in-time and may be out of date.